Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 152 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Skin Red Clear all

Conditions: Neuromuscular Blockade, Intraoperative Monitoring, Skin Preparation, Electromyography
Interventions: Gentle Skin Abrasion Before EMG-Based Neuromuscular Blockade Monitoring; Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Phototherapy
Interventions: LED phototherapy, narrowband UVB phototherapy; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 120 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Erythema, Edema
Interventions: "Chameleon" Personal Lubricant; Device
Lead sponsor: Church & Dwight Company, Inc.; Industry
Eligibility: 18 Years to 69 Years
Enrollment: 222 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Union, New Jersey

Conditions: Erythema, Rosacea
Interventions: CD07805/47 gel 0.5%/CD07805/47 Vehicle, azelaic acid gel 15%; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 4
States / cities: Evansville, Indiana • Louisville, Kentucky • Austin, Texas + 1 more

Conditions: Acne Vulgaris, Post Inflammatory Hyperpigmentation, Post Inflammatory Pigmentation Change, Erythema, Skin Scarring
Interventions: Tazarotene 0.045% Lotion; Drug
Lead sponsor: Dr. Emmy Graber; Other
Eligibility: 18 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Male Pattern Baldness, Female Pattern Baldness
Interventions: low-level laser/light therapy; Device
Lead sponsor: Awareable Technologies Inc; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Ijamsville, Maryland

Conditions: Eyelid Erythema
Interventions: Tegaderm Eye Tape, Transpore Eye Tape; Device
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rosacea
Interventions: Coppertone, BAY1183345; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Lynchburg, Virginia

Conditions: Lyme Disease
Interventions: T-Detect Lyme; Diagnostic Test
Lead sponsor: Adaptive Biotechnologies; Industry
Eligibility: 7 Years and older
Enrollment: 893 participants
Timeline: 2020 – 2021
U.S. locations: 34
States / cities: Danbury, Connecticut • Macon, Georgia • Savannah, Georgia + 29 more

Conditions: Erythema, Rosacea
Interventions: AGN-199201, Vehicle to AGN-199201; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Lynchburg, Virginia

Conditions: Erythema, Rosacea
Interventions: Oxymetazoline HCL Cream 1.0%, Vehicle to Oxymetazoline HCL Cream; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 445 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses
Interventions: Harmonized supportive care, Etanercept 50 mg sc day 1 and day 4; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 14
States / cities: Phoenix, Arizona • Sacramento, California • Washington D.C., District of Columbia + 11 more

Conditions: Asthma, Erythema Toxicum Neonatorum
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 3 Years to 9 Years
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Pressure Ulcers, Tissue Injury
Interventions: Not listed
Lead sponsor: Trillennium Medical Imaging, Inc.; Industry
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Androgenetic Alopecia
Interventions: TopHat 655 rejuvenation system, Laser and/or Light Hair Rejuvenation System; Device
Lead sponsor: Apira Science, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 4
States / cities: Hoboken, New Jersey • New York, New York • Rochester, New York + 1 more

Conditions: Atopic Dermatitis
Interventions: Abrocitinib; Drug
Lead sponsor: Innovaderm Research Inc.; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 6
States / cities: Birmingham, Alabama • Fountain Valley, California • Miami Lakes, Florida + 3 more

Conditions: Alveolar Osteitis, Dry Socket, Infection
Interventions: IV Preoperative antibiotic or placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 13 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy Participants and/or Patients
Interventions: Psoriashield in the presence of a non-UV absorbing block., Psoriashield in the presence of a UV absorbing block., Psoriashield, Xtrac laser in the presence of a non-UV absorbing block., Xtrac in the presence of a UV absorbing block., Xtrac laser; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Post Procedural Erythema
Interventions: Not listed
Lead sponsor: Acorn Biolabs Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 33
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Beverly Hills, California + 24 more

Conditions: Breast Carcinoma, Breast Lump, Edema, Erythema, Estrogen Receptor Negative, HER2/Neu Negative, Inflammatory Breast Carcinoma, Invasive Breast Carcinoma, Peau d'Orange, Progesterone Receptor Negative, Triple-Negative Breast Carcinoma
Interventions: Carboplatin, Laboratory Biomarker Analysis, Paclitaxel, Panitumumab; Drug · Other · Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Erythema, Edema
Interventions: Miami w/ frag Personal lubricant; Device
Lead sponsor: Church & Dwight Company, Inc.; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Skin Ageing, Facial Wrinkles, Acne, Skin Elasticity, Infraorbital Dark Circle Severity, Skin Firmness, UV Spots, Skin Texture, Skin Pores, Brown Spots, Porphyrins, Red Spots
Interventions: NIRA Laser M2.1, Topical; Device · Other
Lead sponsor: NIRA Innovations Inc.; Industry
Eligibility: 35 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Beverly, Massachusetts

Conditions: Erythema
Interventions: MOB015B, 0.2% SLS, 0.9% Saline, MOB015B vehicle; Drug
Lead sponsor: Moberg Pharma AB; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Hidradenitis Suppurativa
Interventions: Ritlecitinib, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 30
States / cities: Hot Springs, Arkansas • Fountain Valley, California • Northridge, California + 22 more

Search by objective public record fields.

Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade Monitoring

Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

Human Repeat Insult Patch Test to Evaluate Personal Lubricants

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne

Low Level Light Therapy (LLLT) for Hair Growth

Tegaderm Vs. Transpore for Eye Protection During Anesthesia

4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness

ImmuneSense Lyme Study

Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea

Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Erythema Toxicum Neonatorum in Newborns and the Development of Asthma

The Analysis of Skin Temperature by Long Wave Infrared Imaging to Determine Its Effectiveness as a Predictor of Tissue Injury

Treatment of Androgenetic Alopecia in Males and Females

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

Antibiotic Efficacy in Third Molar Surgery

MED in UVB Devices in the Presence and Absence of UV Filter

Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects

Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face Wrinkles

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.